Study identifies causes of cancer
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types.
Apr 27, 2022
0
412
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types.
Apr 27, 2022
0
412
Cancer can be a devastating diagnosis, and now two new studies show these patients are at increased risk for anxiety, depression and suicide.
Mar 29, 2022
0
80
The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics. Researchers at the University of Illinois Urbana-Champaign ...
Jan 28, 2022
0
63
Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.
Jan 19, 2022
0
0
Surgeons at Henry Ford Health System's Vattikuti Urology Institute (VUI) have performed what is believed to be the first precision prostatectomy through the bladder using a single port robotic surgical system.
Dec 13, 2021
0
25
Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter research team in the United States has found.
Dec 3, 2021
1
10
A multi-institutional team of investigators led by bioengineer Ankur Singh has developed research tools that shed new light on a virtually untreatable form of prostate cancer, opening a pathway that may lead to novel therapeutics ...
Nov 24, 2021
0
16
Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.
Nov 5, 2021
0
18
In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Principal investigator ...
Oct 8, 2021
0
29
When treating a cancer patient, oncologists aim to predict the course of the patient's disease to make critical treatment decisions. Knowing a tumor's unique molecular signature can help guide these decisions by providing ...
Sep 23, 2021
0
75